BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34239812)

  • 1. Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.
    Bednarsch J; Kather J; Tan X; Sivakumar S; Cacchi C; Wiltberger G; Czigany Z; Ulmer F; Neumann UP; Heij LR
    Liver Cancer; 2021 Jun; 10(3):260-274. PubMed ID: 34239812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Bednarsch J; Tan X; Czigany Z; Liu D; Lang SA; Sivakumar S; Kather JN; Appinger S; Rosin M; Boroojerdi S; Dahl E; Gaisa NT; den Dulk M; Coolsen M; Ulmer TF; Neumann UP; Heij LR
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma.
    Tan X; Bednarsch J; Rosin M; Appinger S; Liu D; Wiltberger G; Garcia Vallejo J; Lang SA; Czigany Z; Boroojerdi S; Gaisa NT; Boor P; Bülow RD; De Vos-Geelen J; Valkenburg-van Iersel L; Clahsen-van Groningen MC; de Jong EJM; Groot Koerkamp B; Doukas M; Rocha FG; Luedde T; Klinge U; Sivakumar S; Neumann UP; Heij LR
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of tumor-associated unilateral portal vein occlusion in perihilar cholangiocarcinoma.
    Bednarsch J; Czigany Z; Heij LR; Luedde T; Wiltberger G; Dulk MD; Bruners P; Lang SA; Ulmer TF; Neumann UP
    HPB (Oxford); 2021 Oct; 23(10):1565-1577. PubMed ID: 33934958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of Nerve Fiber Density as a Prognostic Marker in Predicting Oncological Outcomes in Hepatocellular Carcinoma.
    Bednarsch J; Tan X; Czigany Z; Wiltberger G; Buelow RD; Boor P; Lang SA; Ulmer TF; Neumann UP; Heij LR
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar Cholangiocarcinoma.
    Lurje I; Czigany Z; Bednarsch J; Gaisa NT; Dahl E; Knüchel R; Miller H; Ulmer TF; Strnad P; Trautwein C; Tacke F; Neumann UP; Lurje G
    Liver Cancer; 2022 Apr; 11(2):162-173. PubMed ID: 35634429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma.
    Mantas A; Otto CC; Olthof PB; Heise D; Hoyer DP; Bruners P; Dewulf M; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
    PLoS One; 2024; 19(7):e0304838. PubMed ID: 38950006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of in-hospital transfusion of fresh frozen plasma in patients with cholangiocarcinoma undergoing curative-intent liver surgery.
    Bednarsch J; Czigany Z; Heij LR; Luedde T; Loosen SH; Dulk MD; Bruners P; Lang SA; Ulmer TF; Neumann UP
    Eur J Surg Oncol; 2022 Mar; 48(3):604-614. PubMed ID: 34565633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA).
    Hau HM; Devantier M; Jahn N; Sucher E; Rademacher S; Seehofer D; Sucher R
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
    Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
    World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery.
    Mantas A; Liu D; Otto CC; Heij LR; Heise D; Bruners P; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
    Sci Rep; 2024 Jan; 14(1):1644. PubMed ID: 38238432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition is associated with postoperative complications in perihilar cholangiocarcinoma.
    Wang G; Mantas A; Heij LR; Al-Masri TM; Liu D; Heise D; Schmitz SM; Olde Damink SWM; Luedde T; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
    Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38164056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection.
    Leng KM; Liu YP; Wang ZD; Zhong XY; Liao GQ; Kang PC; Cui YF; Jiang XM
    Onco Targets Ther; 2017; 10():2257-2266. PubMed ID: 28461760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma.
    Zhang Y; Wu Z; Wang X; Li C; Chang J; Jiang W; Wang H; Wang Y; Li X
    BMC Cancer; 2020 Oct; 20(1):1044. PubMed ID: 33126868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group.
    Ruzzenente A; Bagante F; Olthof PB; Aldrighetti L; Alikhanov R; Cescon M; Koerkamp BG; Jarnagin WR; Nadalin S; Pratschke J; Schmelzle M; Sparrelid E; Lang H; Iacono C; van Gulik TM; Guglielmi A;
    Ann Surg Oncol; 2021 Nov; 28(12):7719-7729. PubMed ID: 33956275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup.
    Zhao J; Zhang W; Zhang J; Chen YT; Ma WJ; Liu SY; Li FY; Song B
    Cancer Manag Res; 2020; 12():13111-13123. PubMed ID: 33376403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inguinal lymph node density as a powerful predictor of cancer specific survival in patients with node-positive penile cancer.
    Chavarriaga J; Camacho D; Suso-Palau D; Godoy F; Cabrera M; Forero J; López-de-Mesa B; Varela R
    Urol Oncol; 2021 Dec; 39(12):839.e1-839.e8. PubMed ID: 34400069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma.
    Liu P; Wang Y; Duan L
    Front Oncol; 2022; 12():955670. PubMed ID: 35912230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.